Companies in Africa and India will make generic versions of the pill that could cost as little as $5 per person per year. But ...

Drug-resistant Neisseria gonorrhoeae (the bacterium that causes gonorrhea) has become one of the most urgent antimicrobial-resistant threats to public health worldwide. Clinicians expect to be ...

The 2026 High-Level Meeting on HIV/AIDS was hosted by the UN General Assembly in New York City, NY, USA, from June 22 to 23, 2026. Talha Burki reports.

The White House has disavowed the study, but healthcare workers around the world disagree.

The trace-back investigation for the new outbreak is underway as cases mount across the country. The lettuce originated from ...

The Trump administration’s cuts to the largest global H.I.V. program last year resulted in sharp drops in both prevention ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming participation in the 26th International AIDS Conference ( AIDS 2026 ) taking place in Rio de Janeiro, Brazil, from July 26-31. As a ...

A UCSF study finds controlling HIV is not enough when trauma, addiction, mental illness and housing instability continue to threaten patients' lives.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that new data from its research pipeline for HIV treatment and prevention will be presented at the 26th ...

Millions of HIV/AIDS patients, many of them in Africa, face an uncertain future as a financial cliff-edge for US-funded global programs fast approaches. In September, 120 funding awards for HIV/AIDS ...

For the first three decades of his life, Cody Pharis didn't think much about HIV. Pharis, a gay man, tells PEOPLE that he knew that “the virus had been around” — but the HIV/AIDS pandemic of the '90s ...

The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026. Clinical trials showed close to ...